Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-038767

Director bought 4,000 shares at an average $33.56 ($134,240)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
De Backer Marianne Director 2020-01-13 Purchase +500 $54.95 $27,475 13,000 D: show line 1 in the form
De Backer Marianne Director 2020-02-27 Purchase +500 $35.07 $17,535 13,500 D: show line 2 in the form
De Backer Marianne Director 2020-02-28 Purchase +500 $34.39 $17,195 14,000 D: show line 3 in the form
De Backer Marianne Director 2020-03-11 Purchase +500 $28.60 $14,300 14,500 D: show line 4 in the form
De Backer Marianne Director 2020-03-12 Purchase +500 $24.80 $12,400 15,000 D: show line 5 in the form
De Backer Marianne Director 2020-03-16 Purchase +500 $23.94 $11,970 15,500 D: show line 6 in the form
De Backer Marianne Director 2020-04-15 Purchase +500 $35.40 $17,700 16,000 D: show line 7 in the form
De Backer Marianne Director 2020-06-15 Purchase +500 $31.33 $15,665 16,500 D: show line 8 in the form
Open-market purchases · 4,000 sh · avg $33.56 · $134,240
Loading xslF345X03/doc4.xml…